Methohexital Sodium NDC 83270-003

NDC codes

FDA NDC Directory

Product NDC (as listed)83270-003Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83270-0003Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83270-003-01	83270000301	500 mg in 1 VIAL (83270-003-01)Marketed from Jan 24, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methohexital Sodium
Generic name (nonproprietary): methohexital sodium
Active ingredients: Methohexital sodium — 500 mg/500mg
Dosage form: Injection
Route: Intravenous
Labeler: ONESOURCE SPECIALTY PHARMA LIMITED
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215488
Marketing start: Jan 24, 2026
Listing expires: Dec 31, 2027
DEA schedule: CIV
Other FDA classes: Barbiturates (Chemical structure)
Identifiers: Product ID 83270-003_4b14107a-95d4-0f90-e063-6394a90a0eb3SPL ID 4b14107a-95d4-0f90-e063-6394a90a0eb3SPL set ID 6fb09acf-4937-47a0-a9da-084ec062da6fRxCUI 1244233UNII 60200PNZ7Q
Pharmacologic class: Barbiturate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N483270000301 followed by a unit qualifier and the quantity

Package 83270-0003-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Methohexital Sodium for Injection can be used in adults as follows: 1.For intravenous induction of anesthesia prior to the use of other general anesthetic agents. 2.For intravenous induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for short surgical procedures; Methohexital Sodium for Injection may be given by infusion or intermittent injection. 3.For use along with other parenteral agents, usually narcotic analgesics, to supplement subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for longer surgical procedures. 4.As intravenous anesthesia for short surgical, diagnostic, or t…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215488

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215488
Product	Strength	Form · route	Labeler	Product NDC
Methohexital Sodium	Methohexital sodium 500 mg/500mg	InjectionIntramuscular, Intravenous, Rectal	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	23155-893